BVF PARTNERS L P/IL Insider Trading $CYTK CYTOKINETICS INC
Get free email notifications about insider trading for BVF PARTNERS L P/IL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in CTI BIOPHARMA CORP ($CTIC) and 10% Owner in XOMA Corp ($XOMA) and Director in XOMA Corp ($XOMA) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in INFINITY PHARMACEUTICALS, INC. ($INFI) and in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and 10% Owner in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and in CYTOKINETICS INC ($CYTK) and 10% Owner in CYTOKINETICS INC ($CYTK) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in Syndax Pharmaceuticals Inc ($SNDX) and in Eledon Pharmaceuticals, Inc. ($NVUS) and in ChemoCentryx, Inc. ($CCXI) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in IMMUNE DESIGN CORP. ($IMDZ) and 10% Owner in Calithera Biosciences, Inc. ($CALA) and 10% Owner in Principia Biopharma Inc. ($PRNB) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and 10% Owner in Xenon Pharmaceuticals Inc. ($XENE) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Merus N.V. ($MRUS) and in IDEAYA Biosciences, Inc. ($IDYA) and 10% Owner in IDEAYA Biosciences, Inc. ($IDYA) and Director in Rain Therapeutics Inc. ($RAIN) and Director in Olema Pharmaceuticals, Inc. ($OLMA) and Director in Kymera Therapeutics, Inc. ($KYMR).
BVF PARTNERS L P/IL in CYTOKINETICS INC
Trading Symbol: CYTKIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL:
Holdings: 3,811,271 shares
Current Value: $44,591,871
Latest Transaction: Dec 11 2020
$CYTK Market Capitalization: $461.88M
$CYTK Previous Close: $11.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BVF PARTNERS L P/IL in CYTOKINETICS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALPN, ARQL, CALA, CAPS, CCXI, CNCE, CTIC, CYTK, ELDN, FPRX, GLYC, IDYA, IMDZ, INFI, KYMR, MRUS, OLMA, PIRS, PRNB, RAIN, SNDX, XENE, XOMA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 11 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | Sell | S | 18.00 | 25,486 | 458,748 | 463,244 | 488.7 K to 463.2 K (-5.21 %) | |
Dec 11 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | Sell | S | 18.00 | 166,194 | 2,991,492 | 2,760,185 | 2.9 M to 2.8 M (-5.68 %) | |
Dec 11 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | Sell | S | 18.00 | 239,274 | 4,306,932 | 3,811,271 | 4.1 M to 3.8 M (-5.91 %) | |
Nov 20 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | Option Exercise | J | 20.00 | 93 | 1,860 | 0 | ||
Nov 20 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | Option Exercise | J | 20.00 | 551 | 11,020 | 0 | ||
Nov 20 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | Option Exercise | J | 20.00 | 740 | 14,800 | 0 | ||
Nov 20 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | Option Exercise | J | 20.00 | 93 | 1,860 | 0 | ||
Nov 20 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | Option Exercise | J | 20.00 | 551 | 11,020 | 0 | ||
Nov 20 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | Option Exercise | J | 20.00 | 740 | 14,800 | 0 | ||
Feb 18 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 15.79 | 74,893 | 1,182,321 | 424,419 | 499.3 K to 424.4 K (-15.00 %) |
Feb 18 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 15.79 | 510,793 | 8,063,787 | 2,350,829 | 2.9 M to 2.4 M (-17.85 %) |
Feb 18 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 15.79 | 486,344 | 7,677,815 | 3,131,432 | 3.6 M to 3.1 M (-13.44 %) |
Dec 12 2019 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 9.52 | 8,506 | 80,935 | 499,312 | 490.8 K to 499.3 K (+1.73 %) |
Dec 12 2019 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 9.52 | 49,804 | 473,885 | 2,861,622 | 2.8 M to 2.9 M (+1.77 %) |
Dec 12 2019 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 9.52 | 60,103 | 571,880 | 3,617,776 | 3.6 M to 3.6 M (+1.69 %) |
Dec 12 2019 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 9.40 | 15,030 | 141,282 | 490,806 | 475.8 K to 490.8 K (+3.16 %) |
Dec 12 2019 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 9.40 | 95,100 | 893,940 | 2,811,818 | 2.7 M to 2.8 M (+3.50 %) |
Dec 12 2019 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 9.40 | 113,529 | 1,067,173 | 3,557,673 | 3.4 M to 3.6 M (+3.30 %) |
Page: 1